Bank of America cut shares of Sabra Health Care REIT (NASDAQ:SBRA) from a neutral rating to an underperform rating in a research report report published on Friday, MarketBeat reports. The brokerage currently has $21.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $23.00.

A number of other equities analysts have also recently issued reports on SBRA. ValuEngine cut Sabra Health Care REIT from a sell rating to a strong sell rating in a report on Saturday, July 28th. Zacks Investment Research raised Sabra Health Care REIT from a sell rating to a hold rating in a report on Wednesday, October 31st. BidaskClub raised Sabra Health Care REIT from a hold rating to a buy rating in a report on Saturday, August 18th. Mizuho cut Sabra Health Care REIT from a buy rating to a neutral rating and set a $21.00 target price for the company. in a report on Tuesday, November 13th. Finally, Raymond James cut Sabra Health Care REIT from an outperform rating to a market perform rating in a report on Friday. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $22.36.

Shares of SBRA opened at $19.25 on Friday. Sabra Health Care REIT has a 1 year low of $15.77 and a 1 year high of $23.83. The company has a quick ratio of 2.88, a current ratio of 2.88 and a debt-to-equity ratio of 1.00. The company has a market capitalization of $3.33 billion, a PE ratio of 7.92, a P/E/G ratio of 2.37 and a beta of 0.56.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Monday, November 5th. The real estate investment trust reported $0.20 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.62 by ($0.42). Sabra Health Care REIT had a return on equity of 11.80% and a net margin of 61.85%. The company had revenue of $151.80 million during the quarter, compared to analyst estimates of $162.64 million. As a group, equities research analysts expect that Sabra Health Care REIT will post 2.3 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 30th. Stockholders of record on Thursday, November 15th will be paid a $0.45 dividend. The ex-dividend date is Wednesday, November 14th. This represents a $1.80 annualized dividend and a dividend yield of 9.35%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 74.07%.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tocqueville Asset Management L.P. increased its stake in shares of Sabra Health Care REIT by 11.9% in the 2nd quarter. Tocqueville Asset Management L.P. now owns 21,747 shares of the real estate investment trust’s stock valued at $473,000 after buying an additional 2,306 shares during the period. Wedbush Securities Inc. increased its stake in shares of Sabra Health Care REIT by 11.1% in the 3rd quarter. Wedbush Securities Inc. now owns 24,656 shares of the real estate investment trust’s stock valued at $570,000 after buying an additional 2,457 shares during the period. Nomura Asset Management Co. Ltd. increased its stake in shares of Sabra Health Care REIT by 2.3% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 110,100 shares of the real estate investment trust’s stock valued at $2,546,000 after buying an additional 2,500 shares during the period. Commonwealth Equity Services LLC increased its stake in shares of Sabra Health Care REIT by 14.6% in the 2nd quarter. Commonwealth Equity Services LLC now owns 19,786 shares of the real estate investment trust’s stock valued at $430,000 after buying an additional 2,525 shares during the period. Finally, US Bancorp DE increased its stake in shares of Sabra Health Care REIT by 91.5% in the 2nd quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock valued at $124,000 after buying an additional 2,723 shares during the period. 89.16% of the stock is owned by institutional investors.

About Sabra Health Care REIT

As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: New Google Finance Tool and Screening Stocks

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.